PubMed HealthSearch

Biomedical subjects

E P Pluygers

Publications and source records attributed to E P Pluygers.

4 recordsLinked to original sources

Comparison of CEA polyclonal antibodies, CEA monoclonal antibodies, tissue polypeptide antigen in the sera of supposedly healthy individuals.

Serum determinations of carcinoembryonic antigen (CEA) using both polyclonal antibodies (PAbs) and monoclonal antibodies (MAbs) were carried out in 348 supposedly healthy screenees. A correlation of the two CEA-detection methods was observed for MAb values higher than 0.5 ng/ml, but not for the lower MAb values that failed to detect CEA. Of 162 such cases (46.5% of the total population that were screened by MAbs), only 39 (11.2%) remained undetected by PAbs, with values as high as 3-4 ng/ml. CEA PAbs thus enabled a more subtle analysis of values in the lower range, a potentially useful factor in screening. In 18 screenees (5.1%) the values were above 2 SD of the mean by MAbs against 13 by PAbs; values above 3 SD were present in three by MAbs and in none by PAbs. In 14 of 18 cases high CEA values were related to smoking and to chronic gastrointestinal disease. The suggested specificity of CEA MAbs for cancer cells thus could not be confirmed because no cancer was detected in this series. Elevated tissue polypeptide antigen values were observed in 14 individuals and were not correlated with either CEA or smoking. Estrogens and estrogen-progestogens were administered to five females whereas four males had gynecomasty, and in three cases leukemia was reported among close relatives.

Adult

Tumor markers for cancer detection. I.

We report a prospective study aimed at assessing the value of serum marker determinations in a supposedly healthy population to detect cancer and to identify individuals at high risk. We analyzed a group of 1,611 supposedly healthy subjects attending a cancer detection center, over a 1-5 year period and a control group of 100 cancer patients. Repeated determinations of the following markers were made: CEA, AFP, HCG, beta-HCG, beta 2-M, ferritin, beta 1-SP, all by radioimmunoassay. In the literature, marker determinations are considered not to be useful for cancer screening; in spite of this, we determined "normal" and "suspicious" levels for each marker and were able to define a group "at risk" that may harbor an early cancer (representing 23.6% of the total) and a "normal" group. The cancer detection rate was 45 0/00 (17/378) in the risk group and 3.2 0/00 in the "normal" one (4/1233). Our data show that markers could play a role in cancer screening.

Adult

Tumor markers for cancer detection. II.

Updated results of a prospective study assessing the value of tumor marker determinations in a supposedly healthy population (2,000) for identification of a group at risk for cancer are reported. With observation periods varying from 1 to 6 years (mean 3.5 years), repeated determinations by RIA were routinely carried out for CEA, AFP, beta-HCG, beta 2-M, ferritin, and, more recently, beta 1-SP. Preliminary data on TPA, CA 12-5, and CA 19-9 were also obtained. A comparative study of methods for CEA determination using monoclonal and polyclonal antibodies revealed that preference should be given to polyclonal antibodies. In the group considered to be "at risk" (ie, having at least one abnormal marker value) (N = 481), the cancer detection rate was 29 per 1,000 against 3.2 per 1,000 in the normal group (N = 1,519). These figures were significant, even if the number of malignancies detected was small (N = 27). By associating general tumor markers such as CEA, TPA, and CA 19-9 with site-specific markers such as PAP and CA 12-5, it seemed that marker determinations played a useful role in risk assessment in cancer detection programs.

Adolescent

Biomarkers.

Explore the source record for details and available documents.

Animals